Idexx Laboratories Inc executive vice president Michael Lane sells $2.74M of IDXX shares
The executive vice president sold at an average of $688.64 a share, according to a Form 4 filed with the SEC on Nov 5.
Michael Lane sold about $2.7 million of Idexx Laboratories Inc (IDXX) stock on Nov 4, according to an SEC filing. The executive vice president received an average of $688.64 for 3,979 shares.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The sale reduces the insider's holding by 49%, to 4,076 shares.
Four Idexx Laboratories Inc insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Idexx Laboratories Inc (IDXX) |
|---|---|
| Insider | Michael Lane |
| Role | Executive Vice President |
| Transaction | Open-market sale (code S) |
| Shares | 3,979 |
| Average price | $688.64 |
| Value | $2,740,069 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 5, 2026, 5:01 PM ET |
| Shares held after | 4,076 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
Browse the insider trading newsroom · See earlier insider stories on Idexx Laboratories Inc
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
